These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26908847)

  • 21. Seizures and sideroblastic anaemia in a patient with multidrug-resistant tuberculosis.
    Vigneshwaran J; Kumar MS; Raghavan V; Sundari S
    Lancet; 2022 Jan; 399(10322):393. PubMed ID: 35065787
    [No Abstract]   [Full Text] [Related]  

  • 22. Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
    Koh WJ; Kwon OJ; Gwak H; Chung JW; Cho SN; Kim WS; Shim TS
    J Antimicrob Chemother; 2009 Aug; 64(2):388-91. PubMed ID: 19468028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linezolid-resistant
    Bharadwaj R
    Indian J Med Res; 2021 Jul; 154(1):16-18. PubMed ID: 34782525
    [No Abstract]   [Full Text] [Related]  

  • 24. Partial intestinal obstruction due to clofazimine in a patient with multidrug-resistant tuberculosis.
    Usküdar O; Köksal D; Köksal AS
    Int J Tuberc Lung Dis; 2005 Jun; 9(6):703-4. PubMed ID: 15971405
    [No Abstract]   [Full Text] [Related]  

  • 25. [The analysis of clinical data about the treatment of linezolid against tuberculosis].
    Nie WJ; Chu NH
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):601-3. PubMed ID: 24252739
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical outcomes of linezolid treatment for extensively drug-resistant tuberculosis in Beijing, China: a hospital-based retrospective study.
    Liu Y; Bao P; Wang D; Li Y; Tang L; Zhou Y; Zhao W
    Jpn J Infect Dis; 2015; 68(3):244-7. PubMed ID: 25672406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: updated analysis of 51 patients.
    Koh WJ; Kang YR; Jeon K; Kwon OJ; Lyu J; Kim WS; Shim TS
    J Antimicrob Chemother; 2012 Jun; 67(6):1503-7. PubMed ID: 22403262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A patient of multidrug-resistant tuberculosis on category IV treatment regimen presenting with psychosis.
    Sarkar S; Sood M
    Natl Med J India; 2011; 24(4):244-5. PubMed ID: 22208150
    [No Abstract]   [Full Text] [Related]  

  • 29. Association Between Increased Linezolid Plasma Concentrations and the Development of Severe Toxicity in Multidrug-Resistant Tuberculosis Treatment.
    Eimer J; Fréchet-Jachym M; Le Dû D; Caumes E; El-Helali N; Marigot-Outtandy D; Mechai F; Peytavin G; Pourcher V; Rioux C; Yazdanpanah Y; Robert J; Guglielmetti L;
    Clin Infect Dis; 2023 Feb; 76(3):e947-e956. PubMed ID: 35717636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Linezolid for multidrug-resistant tuberculosis.
    Chang KC; Leung CC; Daley CL
    Lancet Infect Dis; 2012 Jul; 12(7):502-3. PubMed ID: 22742623
    [No Abstract]   [Full Text] [Related]  

  • 31. A death associated with therapy for nosocomially acquired multidrug-resistant tuberculosis.
    Weltman AC; DiFerdinando GT; Washko R; Lipsky WM
    Chest; 1996 Jul; 110(1):279-81. PubMed ID: 8681641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.
    Rose PC; Hallbauer UM; Seddon JA; Hesseling AC; Schaaf HS
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1588-93. PubMed ID: 23032215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
    Yew WW; Chang KC; Chau CH
    J Antimicrob Chemother; 2009 Nov; 64(5):1119; author reply 1119-20. PubMed ID: 19666903
    [No Abstract]   [Full Text] [Related]  

  • 34. Drugs for tuberculosis.
    Med Lett Drugs Ther; 1993 Oct; 35(908):99-101. PubMed ID: 8412982
    [No Abstract]   [Full Text] [Related]  

  • 35. Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis--authors' response.
    Koh WJ; Shim TS
    J Antimicrob Chemother; 2009 Nov; 64(5):1119-20. PubMed ID: 19744986
    [No Abstract]   [Full Text] [Related]  

  • 36. [Consensus on linezolid in the treatment of tuberculosis(2022 update)].
    Chinese Society for Tuberculosis, Chinese Medical Association
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Oct; 45(10):988-995. PubMed ID: 36207955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patients.
    Bolhuis MS; van Altena R; van Soolingen D; de Lange WC; Uges DR; van der Werf TS; Kosterink JG; Alffenaar JW
    Eur Respir J; 2013 Dec; 42(6):1614-21. PubMed ID: 23520311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Linezolid-induced black hairy tongue in a patient with multidrug-resistant tuberculosis: A case report.
    Lee J; Chung HS; Roh J; Oh Y; Mok J
    Sci Prog; 2021; 104(3):368504211042982. PubMed ID: 34541939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic drug management: is it the future of multidrug-resistant tuberculosis treatment?
    Srivastava S; Peloquin CA; Sotgiu G; Migliori GB
    Eur Respir J; 2013 Dec; 42(6):1449-53. PubMed ID: 24293417
    [No Abstract]   [Full Text] [Related]  

  • 40. Amikacin treatment for multidrug resistant tuberculosis: how much monitoring is required?
    Melchionda V; Wyatt H; Capocci S; Garcia Medina R; Solamalai A; Katiri S; Hopkins S; Cropley I; Lipman M
    Eur Respir J; 2013 Oct; 42(4):1148-50. PubMed ID: 24081766
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.